PHARMACEUTICAL MICROBIOLOGY - V. A. Galynkin - 2015

Introduction

This textbook covers the Morphology, ultrastructure, physiology, and Genetics of Bacteria, Fungi, Viruses, and Protozoa, tailored specifically for professionals working in the field of Pharmaceuticals and drug Circulation. It highlights key issues in biotechnology, as well as genetic and cellular engineering. The fundamentals of microbial pathogenicity, along with the Etiology and Chemotherapy of infectious diseases, are thoroughly addressed. The basics of immunology are presented in direct connection with the manufacturing requirements of IMMUNOBIOLOGICAL PRODUCTS. The section entitled "Microbiological Aspects of Pharmaceutical Activities" examines quality standards for medicinal products and strategies for quality enhancement through the control of contaminating microorganisms and adherence to GMP principles. In recent years, the pharmaceutical industry has seen a significant expansion in the variety of herbal raw Materials and phytopharmaceuticals. Medicinal plant materials (MPM), which serve as the foundation for herbal remedies, are naturally contaminated with microflora and represent the primary vector for microbial spores. A vast array of foreign living organisms and synthetic chemicals continually circulate in the biosphere, and plant microbial contamination heavily depends on environmental factors such as soil, air, and Water. Investigating plant-microbe interactions is one of the most fascinating and rapidly growing fields in modern biology. These interactions play a critical role in plant life, supporting Nutrition and providing defense against pathogens and pests. Today, Antibiotic Resistance has escalated into a global crisis; in the European Union alone, over 25,000 people die annually from Infections caused by resistant strains. Overcoming this resistance is closely tied to developing next-generation Antibiotics based on novel antimicrobial agents, both natural and synthetic, such as antimicrobial Peptides (AMPs). AMPs of the innate immune system form the backbone of anti-infective defense in humans, animals, and plants. Current research focuses on exploring their Structure/179.html">Practical Applications and developing antimicrobial therapeutics with optimal properties. Among naturally occurring antimicrobial agents, human, animal, and plant antibiotic peptides have received intensive study as key immune-defense factors of the innate immune system. AMPs exhibit potent antimicrobial, antiviral, and antitumor activity, largely due to their rapid membrane-disrupting MECHANISM OF ACTION.

In recent years, risk management has become increasingly crucial amid rising market competition and a growing responsibility for executives—not only regarding product quality, but also in overall decision-making. Safety and risk management in the pharmaceutical and biotechnology sectors must be addressed comprehensively from multiple Perspectives. A pharmaceutical product can pose risks as a business commodity, a social asset, and an information resource. Risk management standards developed by FERMA are soon expected to be adopted as international ISO standards. Currently, pharmaceutical companies are actively working to integrate GMP systems into drug manufacturing. In practice, aligning pharmaceutical production with GMP standards establishes the essential framework for producing safe, high-end medicinal products. Hazard Analysis Critical Control Point (HACCP) systems represent a fundamental step toward adopting Good Practice regulations. The immediate Implementation of HACCP principles in pharmaceutical manufacturing provides a high degree of assurance regarding the quality and safety of the final pharmaceutical product. The second edition of Russia's pioneering higher-education textbook features new sections contributed by A. E. Gabitova:

— GAP — Good Agricultural Practice;

— MICROFLORA OF MEDICINAL plant raw materials;

— Plant-microbe interactions during GROWTH AND DEVELOPMENT:

— Microbial contamination of plants;

— Mycorrhizal microorganisms;

— Epiphytic microflora;

— Phytopathogenic fungi;

— Phytopathogenic bacteria;

— Symptomatology of plant diseases and types of bacterioses;

— Mycoplasmas (PHYTOPLASMAS) Plant viruses.

Several chapters of the textbook have also been updated to cover microbiological risk and risk management within GMP and HACCP frameworks.

This book is intended for microbiologists, pharmacists, pharmaceutical production technologists, and students in higher education institutions majoring in Pharmacy (060108), Biotechnology (240901), Food Biotechnology (240902), and Microbiology (020209), as well as a wide range of professionals involved in the circulation of medicines.